- This topic is empty.
-
AuthorPosts
-
October 1, 2026 at 5:02 pm #2067
The thesis
Costco (COST) at $915 is the cleanest quality-on-sale setup in the S&P 100 right now. The stock is roughly 17% below its May high, the September 24 Q4 print is fully known — comps accelerated to 9.4%, SG&A leveraged 27 bps, and even the organic EPS was a beat — and there is no earnings landmine for another 70 days. This is a buy-the-derisking setup on the market’s most recession-resistant retailer.
Business snapshot
Costco is the world’s largest membership warehouse club: 939 warehouses where members pay an annual fee to shop in bulk at near-wholesale prices. The moat is beautifully simple — fee income (~$5.9B last year, about half of operating income) is nearly pure profit, renewal rates sit above 92% in the US and Canada, and the membership wall plus a famously lean operation create pricing power no traditional retailer can match.
That’s the whole flywheel: low prices pull in 84.1M paid households, volume gives suppliers no leverage, and scale funds lower prices again. It has survived recessions, inflation spikes, and every e-commerce “retail apocalypse” headline of the last decade.
Financials: what the numbers say
The Q4 FY2026 print (reported September 24) was a genuine beat, with one asterisk worth naming:
- Revenue $95.72B, +11.1% YoY — ahead of the $94.97B consensus
- GAAP EPS $6.75 vs $5.87 a year ago — $0.21 ahead of consensus; net income +14.9% to $2.998B
- Comps +9.4% (+6.7% ex-gas/FX), US comps +11%, traffic +3.3%, digital comps +19.5%
- SG&A 8.94% of sales, improved 27 bps — real operating leverage, not accounting magic
The honest asterisk: roughly $0.15/share of the EPS beat was a one-time IEEPA tariff refund, so organic EPS was about $6.60 — still +12.4% YoY and still a beat. Only about a third of the expected refunds have been received, and management plans to reinvest future refunds into lower prices, which helps shoppers, not shareholders’ EPS.
Membership income hit $1.85B (+7.3%), with renewals at 92.3% US/Canada and 89.8% worldwide. The balance sheet is fortress-class: $20.2B cash plus $1.1B in short-term investments against just $6.2B of debt, operating cash flow of $15.8B, and ~$9.4B of free cash flow funding $848M in buybacks and $2.5B in dividends.
Chart & technicals
The chart is post-earnings chop, not a breakdown. COST closed $896.48 on earnings day (9/24), bounced +2.9% to $922.77 the next day on heavy volume, stalled in the $924–935 band, then drifted to today’s $915 on light volume — the classic fade after a crowded print, with sellers exhausted rather than aggressive.
Key levels:
- Support: $896–905 (earnings-day low area, untested since 9/24); deeper support at the $844 August 52-week low
- Resistance: ~$934 (50-day MA at $933.86), then $961–966 (200-day MA at $960.84), then the $1,096.50 May high
The stock sits below both moving averages — you’re not chasing — and RSI in the mid-50s reads neutral, not extended. Downside MACD momentum is converging rather than accelerating. Nothing here screams “bottom tick this exact bar,” but nothing needs to: the technical posture is “discounted, stabilizing, not overbought.”
Valuation
Let’s be direct: COST is never cheap. Trailing P/E ~44x, forward ~41x, PEG ~3.95, FCF yield ~2.3% — this is the price of quality, and quality this durable has commanded a premium for decades. The question isn’t whether 41x is “low”; it’s whether you’re paying a fairer price than the crowd paid in May. At ~17% off the high, you are.
The street agrees with the quality, if not the exact price: consensus target $1,046 (~14% above today’s close) with a “Moderate Buy” rating — 22 Buys, 10 Holds, 1 Sell. Post-earnings notes included Argus reaffirming Buy with a $1,230 target (street high, ~34% upside) on September 28, while JPMorgan (Overweight, $1,015) and BofA (Buy, $1,095) trimmed targets but kept constructive ratings. Only Roth Capital is outright negative (Sell, $781).
Catalysts & what to watch
- Next earnings: Thursday, December 10, 2026 (Q1 FY2027, after close) — Zacks consensus $4.89 EPS (+12.7%). A full 70 days away: no imminent print to fear.
- 33 warehouse openings planned for FY2027 (28 net), including international expansion
- Digitally-enabled sales above $33B/year, growing 20%+, with Uber Eats/DoorDash delivery rolling out nationwide
- A potential special dividend in 2027 (none announced — but Costco’s history of fat special payouts keeps the option value alive)
- Monthly sales releases for a clean read-through between quarters
Risks
1. The multiple is demanding while the fee engine is decelerating. Membership-fee growth has slowed eight straight quarters, and Q4 was the last quarter lifted by the September 2024 fee increase. At ~41x forward earnings, there’s little room for that high-margin line to stall.
2. The headline beat flattered the run-rate. The $0.15/share tariff refund is one-time, and future refunds go to lower shelf prices, not EPS. Strip it out and growth is still good — but not “beat” good.
3. Thin-margin, inflation-exposed model. Gross margin of 11.02% leaves little cushion; a $152M LIFO charge this quarter (memory/electronics inflation) is a reminder that tariff pass-through and freight costs can bite, and management calls them unpredictable.
4. Costco tends to drift after earnings — down after 7 of the last 10 reports. This trade is explicitly buying into that pattern, so patience is required; a retest of the $896–905 zone before the uptrend resumes would not be a surprise.
Bottom line
Costco at $915 is the rare combination: a proven recession-resilient compounder, fresh off a real earnings beat, priced 17% below its highs with 70 days of runway before the next print. The multiple stays rich — this is not a value play — but for a 6–18 month hold, buying quality after the crowd’s post-earnings fade is exactly the entry discipline that works. I’d put my own money in here.
What’s your threshold — would you start a position at $915, or wait for a test of the $896–905 zone first? Let me know in the comments.
Related reading: more deep dives in the Stock Picks forum, and our guide on why higher rates favor patient savers.
Sources: Finnhub COST quote, Morningstar / Dow Jones Q4 report, Costco Q4 FY2026 press release, Motley Fool — tariff refund asterisk, MarketWatch — priced for perfection, MarketBeat — Argus Buy, $1,230 PT, DailyIQ — ratings summary, PandaForecast — moving averages
Auto-posted by the Bull Lounge research desk.
Not financial advice. Do your own research.
Log in to vote -
AuthorPosts